Mixed prevent virus HIV drugs help patients live an average 13 more years, even if they started using drugs at age 20 may live to age 43 years, research was published in Lancet.
The study was conducted on 43 thousand HIV-infected patients living in the United States, Canada and some European countries - who were treated with a mixture of drugs to control HIV virus.
Dr. Robert Hogg, the British Columbia Center - a center for advances in the treatment of HIV / AIDS in Vancouver (Canada) and colleagues found that: In the period from 1996 to 1999 and from 2003 to 2005, there was a significantly increased life expectancy - about 13 years for patients aged 20 and patients aged 35 also have the same life expectancy increases.
The report also said the average life expectancy of people with HIV-negative at age 20 in these countries is 80 years old. "A person aged 20 starting combination therapy can live to 43 years old."
In another study also published in Lancet, Robert Bollinger doctors at Johns Hopkins University in Baltimore and an international research team has discovered that if the infant daily medication Nevirapine - a anti-AIDS drugs are now widely used to prevent transmission of HIV from mother to child and may increase the resistance of the virus until they are 6 weeks of age could protect them from AIDS.
A study was conducted on 1900 infants showed that if they take medication for weekly instead of simply taking the mother during pregnancy and the baby taking birth mother as soon as he can reduce infection rates up to 46%.
Doctors believe the breastfeeding mother will bring benefits in excess in poor countries, where lack of water and can hardly meet the treatment formula for infants.
Currently about 33 million people worldwide infected with AIDS virus and 25 million people have died since the epidemic began raging 80 years.
The study was conducted on 43 thousand HIV-infected patients living in the United States, Canada and some European countries - who were treated with a mixture of drugs to control HIV virus.
Dr. Robert Hogg, the British Columbia Center - a center for advances in the treatment of HIV / AIDS in Vancouver (Canada) and colleagues found that: In the period from 1996 to 1999 and from 2003 to 2005, there was a significantly increased life expectancy - about 13 years for patients aged 20 and patients aged 35 also have the same life expectancy increases.
The report also said the average life expectancy of people with HIV-negative at age 20 in these countries is 80 years old. "A person aged 20 starting combination therapy can live to 43 years old."
In another study also published in Lancet, Robert Bollinger doctors at Johns Hopkins University in Baltimore and an international research team has discovered that if the infant daily medication Nevirapine - a anti-AIDS drugs are now widely used to prevent transmission of HIV from mother to child and may increase the resistance of the virus until they are 6 weeks of age could protect them from AIDS.
A study was conducted on 1900 infants showed that if they take medication for weekly instead of simply taking the mother during pregnancy and the baby taking birth mother as soon as he can reduce infection rates up to 46%.
Doctors believe the breastfeeding mother will bring benefits in excess in poor countries, where lack of water and can hardly meet the treatment formula for infants.
Currently about 33 million people worldwide infected with AIDS virus and 25 million people have died since the epidemic began raging 80 years.
